Central Nervous System

Question 1

Conducting an action potential down the axon of the neuron

a. Synaptic Transmission
b. Axonal Conduction
c. both a and b

Answer 1

b. Axonal Conduction

Question 2

Process by which information is carried across the gap between neuron and postsynaptic cell

a. Synaptic Transmission
b. Axonal Conduction
c. both a and b

Answer 2

a. Synaptic Transmission

Question 3

How many compounds do CNS contains that serve as neurotransmitter?

a. 21
b. 23
c. 30

Answer 3

a. 21

Question 4

Decreased response occurring in the course of prolonged drug use

a. Tolerance
b. Physical dependence
c. both a and b

Answer 4

a. Tolerance

Question 5

State in which abrupt discontinuation of drug use will precipitate a withdrawal syndrome

a. Tolerance
b. Physical dependence
c. both a and b

Answer 5

b. Physical dependence

Question 6

It is most commonly prescribed anticonvulsant drug

a. Phenobarbital
b. Carbamazepine
c. Phenytoin

Answer 6

c. Phenytoin

Question 7

Effective against partial seizures and generalized tonic-clonic seizures but not absence seizures. Can be used as daytime sedative “sleeping pills”

a. Phenobarbital
b. Carbamazepine
c. Phenytoin

Answer 7

a. Phenobarbital

Question 8

Active against partial seizures and tonic-clonic seizures but not absence of seizures

a. Phenobarbital
b. Carbamazepine
c. Phenytoin

Answer 8

b. Carbamazepine

Question 9

It is restricted to acute treatment of status epilepticus, not recommended for long-term use due to high potential for addiction

a. Diazepam
b. Clonazepam
c. IV Lorazepam

Answer 9

a. Diazepam

Question 10

DOC for acute management of status epilepticus

a. Diazepam
b. Clonazepam
c. IV Lorazepam

Answer 10

c. IV Lorazepam

Question 11

A treatment for absence seizures

a. Diazepam
b. Clonazepam
c. IV Lorazepam

Answer 11

b. Clonazepam

Question 12

What is the therapeutic level for Phenytoin?

a. 50-100 mg/ml
b. 10-20 mcg/ml
c. 4- 12 mcg/ml

Answer 12

b. 10-20 mcg/ml

Question 13

What is the therapeutic level for Carbamazepine?

a. 50-100 mg/ml
b. 10-20 mcg/ml
c. 4- 12 mcg/ml

Answer 13

c. 4-12 mcg/ml

Question 14

What is the therapeutic level for Carboxylic acid?

a. 50-100 mg/ml
b. 10-20 mcg/ml
c. 4- 12 mcg/ml

Answer 14

a. 50-100 mg/ml

Question 15

An abstinence maintenance that decreases unpleasant effects resulting from abstinence (anxiety/restlessness)

a. Buprenorphine (subutex)
b. Acamprosate
c. Naltrexone
d. Clonidine (catapres)

Answer 15

b. Acamprosate

Question 16

An abstinence maintenance, opioid antagonist that suppresses craving and pleasurable effects of alcohol

a. Buprenorphine (subutex)
b. Acamprosate
c. Naltrexone
d. Clonidine (catapres)

Answer 16

c. Naltrexone

Question 17

Opioid withdrawal support, Aids in withdrawal effects related to autonomic hyperactivity (diarrhea, nausea, vomiting)

a. Buprenorphine (subutex)
b. Acamprosate
c. Naltrexone
d. Clonidine (catapres)

Answer 17

d. Clonidine (catapres)

Question 18

Opioid withdrawal support, Used for detoxification and maintenance, decreases craving, administered SL, MI, IV

a. Buprenorphine (subutex)
b. Acamprosate
c. Naltrexone
d. Clonidine (catapres)

Answer 18

a. Buprenorphine (subutex)

Question 19

Bind to a carrier protein and act at a receptor resulting in increased GABA in the brain

a. Baclofen
b. Gabapentin
c. Dantrolene sodium

Answer 19

b. Gabapentin

Question 20

Most effective for spasticity of cerebral origin and used for treatment malignant hyperthermia

a. Baclofen
b. Gabapentin
c. Dantrolene sodium

Answer 20

c. Dantrolene sodium